Business · en
Ozempic-maker accuses rival of false advertising
Novo Nordisk has launched legal action accusing Eli Lilly of creating "misleading" ads, a claim its rival denies.
Related index pages
World · BBC NewsTest that found source of US explosive diarrhoea outbreak was false positive, health officials say
The latest update from the US Food and Drug Administration means the exact source of the parasite is still not known.Read original ↗
World · Nikkei AsiaLast German bike helmet maker moves production to China
HAMBURG, Germany -- When family-run German bicycle helmet manufacturer KED announced it would move its entire production process to China later this yRead original ↗
Business · CryptoRank · 3 sourcesApple Stock Price Prediction: Can July Earnings Push AAPL Past $5 Trillion?
Trending now in Taiwan · 100+ searches. Google Trends signal; no generative summary.Read original ↗
Business · Nikkei AsiaIndia's SBI Funds Management ends flat after market debut
MUMBAI -- Shares of SBI Funds Management, India's largest asset manager, closed roughly flat against their opening price on its first day of trading aRead original ↗
Business · Nikkei AsiaMalaysian electric vehicle sales overtake hybrids as market shifts
KUALA LUMPUR -- Sales of electric vehicles (EVs) in Malaysia more than doubled in the first half of 2026, overtaking hybrids for the first time and heRead original ↗
Business · NPR